Fidelity Select Medical Technology and Devices Portfolio (FSMEX)

Fund Assets	3.54B
Expense Ratio	0.602%
Min. Investment	$0.00
Turnover	54.00%
Dividend (ttm)	n/a
Dividend Yield	n/a
Dividend Growth	n/a
Payout Frequency	Semi-Annual
Ex-Dividend Date	Apr 10, 2026

Previous Close	55.97
YTD Return	9.37%
1-Year Return	16.52%
5-Year Return	8.00%
52-Week Low	40.40
52-Week High	65.58
Beta (5Y)	0.81
Holdings	58
Inception Date	Apr 28, 1998

About FSMEX

Fidelity Select Medical Technology and Devices Portfolio is an equity mutual fund focused on the medical technology and devices sector. Its primary goal is capital appreciation by investing at least 80% of its assets in companies that are principally engaged in the research, development, manufacture, distribution, or sale of medical equipment and related technologies. The fund employs an active management strategy, anchored in rigorous, bottom-up fundamental analysis performed by Fidelity’s dedicated health care investment team. Key areas of evaluation include free cash flow, capital allocation, market opportunities, and the potential for sustainable long-term growth. The portfolio is diversified within the health care equipment and technology industry, featuring holdings in leading innovators such as Danaher, Boston Scientific, and Thermo Fisher Scientific. By concentrating investments in companies with strong growth prospects and disruptive technologies, the fund plays a significant role in providing targeted exposure to the evolving healthcare technology space, which is critical to modern health care delivery and advancement.

• Fund Family: Fidelity
• Category: Health
• Performance Rating: Below Average
• Risk Rating: Average
• Stock Exchange: Nasdaq
• Ticker Symbol: FSMEX
• Index: S&P 500 TR

Performance

FSMEX had a total return of 16.52% in the past year, including dividends. Since the fund's inception, the average annual return has been 13.21%.

Top 10 Holdings

63.41% of assets

Name	Symbol	Weight
Thermo Fisher Scientific Inc.	TMO	17.59%
Danaher Corporation	DHR	14.04%
Intuitive Surgical, Inc.	ISRG	5.29%
Waters Corporation	WAT	4.27%
West Pharmaceutical Services, Inc.	WST	4.08%
Agilent Technologies, Inc.	A	3.90%
Boston Scientific Corporation	BSX	3.85%
10x Genomics, Inc.	TXG	3.73%
Abbott Laboratories	ABT	3.46%
Stryker Corporation	SYK	3.19%

Dividend History

Ex-Dividend	Amount	Pay Date
Apr 10, 2026	$6.542	Apr 13, 2026
Dec 12, 2025	$2.990	Dec 15, 2025
Apr 11, 2025	$1.678	Apr 14, 2025
Dec 13, 2024	$4.640	Dec 16, 2024
Apr 12, 2024	$1.315	Apr 15, 2024
Apr 8, 2022	$1.109	Apr 11, 2022

Data Sources: Tiingo, Financial Modeling Prep, and more

Historical data is provided by Tiingo. Delayed stock pricing data is provided by Financial Modeling Prep. Several fund data points are also provided by Finnhub.

Last checked:

Oct 16, 2026

Data Sources Report a data error